JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;133:1481-1482
© 2007 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Discussion

The first 20% of the full text of this article appears below.

Dr J. Coselli (Houston, Tex). Dr Roselli, congratulations on an outstanding presentation. You and your colleagues have boldly built upon a successful track record for the endovascular treatment of abdominal aortic aneurysms and a growing experience with the endovascular exclusion of juxtarenal and descending thoracic aneurysms with this innovative approach, allowing now for treatment of those aneurysms traversing the visceral aortic segment. This is indeed a significant contribution to demonstrate the feasibility of this alternative approach to the open operation from which no doubt many patients have benefited. It is notable that you have been able to demonstrate that the endovascular procedure can be carried out in many cases under regional anesthesia.

A few questions. It is a shame that this study could not have been carried out alongside controls, particularly in view of the fact that the data provided regarding the Gore TAG graft is such that at 2 years, there was no demonstrated difference in the survival rates. Additionally, I would like for you to comment on your postoperative anticoagulation regimen for these patients, and if you could, explain to us why you would not recommend the use of cerebrospinal fluid drainage in all of your patients? Because 2 of your spinal cord problems postoperatively were delayed, would you recommend the insertion of a cerebrospinal fluid catheter in such cases? And then, regarding this particular innovative technology, would you comment, based upon your experience, on the requirements for the training and qualifications for the implementation of such therapy?

Again, congratulations.

Dr Eric E. Roselli . . . [Full Text of this Article]


Related Article

Endovascular treatment of thoracoabdominal aortic aneurysms
Eric E. Roselli, Roy K. Greenberg, Kathryn Pfaff, Catherine Francis, Lars G. Svensson, and Bruce W. Lytle
J. Thorac. Cardiovasc. Surg. 2007 133: 1474-1482. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.